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Background: Intakes of whole grains and cereal fiber have been inversely associated with the risk of chronic
diseases; however, their relation with total and disease-specific mortality remain unclear. We aimed to prospectively
assess the association of whole grains and cereal fiber intake with all causes and cause-specific mortality.
Methods: The study included 367,442 participants from the prospective NIH-AARP Diet and Health Study (enrolled
in 1995 and followed through 2009). Participants with cancer, heart disease, stroke, diabetes, and self-reported
end-stage renal disease at baseline were excluded.
Results: Over an average of 14 years of follow-up, a total of 46,067 deaths were documented. Consumption of
whole grains were inversely associated with risk of all-cause mortality and death from cancer, cardiovascular disease
(CVD), diabetes, respiratory disease, infections, and other causes. In multivariable models, as compared with
individuals with the lowest intakes, those in the highest intake of whole grains had a 17% (95% CI, 14–19%) lower
risk of all-cause mortality and 11–48% lower risk of disease-specific mortality (all P for trend <0.023); those in the
highest intake of cereal fiber had a 19% (95% CI, 16–21%) lower risk of all-cause mortality and 15–34% lower risk of
disease-specific mortality (all P for trend <0.005). When cereal fiber was further adjusted, the associations of whole
grains with death from CVD, respiratory disease and infections became not significant; the associations with all-
cause mortality and death from cancer and diabetes were attenuated but remained significant (P for trend <0.029).
Conclusions: Consumption of whole grains and cereal fiber was inversely associated with reduced total and
cause-specific mortality. Our data suggest cereal fiber is one potentially protective component.
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Grains, also called cereals, are the seeds of plants cul-
tivated for food. When whole, they include the germ,
bran, and endosperm [1]. Most whole grains are abun-
dant sources of dietary fiber and other nutrients, such
as minerals and antioxidants, which have shown benefi-
cial effects on human health including improvement of
weight loss, insulin sensitivity, and lipid profile, as well
as inhibition of systemic inflammation [2-4].* Correspondence: nhlqi@channing.harvard.edu
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unless otherwise stated.In epidemiology studies, evidence is accumulating in-
dicating that consumption of whole grain products or
their effective components, especially dietary fiber found
in the grain, i.e., cereal fiber, may reduce the risk of
chronic disease. Several recent meta-analyses taking in-
to account a large number of subjects and prospective
studies showed significant and consistent protective ef-
fects of high intake of whole grains and cereal fiber on
type 2 diabetes [5], cardiovascular disease (CVD) [6],
and certain cancers (e.g., colorectal cancer) [7]. In our
earlier analysis in the Nurses’ Health Study, we ob-
served potential protective effects of whole grains on
total or cardiovascular mortality in diabetic women [8].
Although the National Institutes of Health (NIH)-AARP
Diet and Health Study previously reported that dietaryThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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death and death from CVD, infectious diseases, and
respiratory diseases [9], few studies have prospectively
examined the associations of whole grains and its com-
ponents, such as cereal fiber, with total or disease-
specific mortality.
In the present study, we used data from 367,442 peo-
ple who were at risk for a total of 12.3 million person-
years. We aimed to provide reliable estimates of inde-
pendent associations between baseline whole grains and
cereal fiber intake and the risk of total or cause-specific
death from CVD, cancers, diabetes, and other diseases.Methods
Study population
The NIH-AARP Diet and Health Study included
566,399 AARP members aged 50 to 71 from six US states
(California, Florida, Louisiana, New Jersey, North Carolina,
and Pennsylvania) and two metropolitan areas (Atlanta,
Georgia, and Detroit, Michigan) [10]. Participants res-
ponded to a questionnaire mailed in October 1995 and
December 1997. Details of the NIH-AARP Study have
been previously described [11]. Among participants who
returned the questionnaires with satisfactory dietary data,
we excluded individuals who indicated that they were
proxies for the intended respondent (n = 15,760) as well
as those who had cancer (n = 50,591), heart disease
(n = 80,254), stroke (n = 12,812), diabetes (n = 52,647),
or self-reported end-stage renal disease at baseline (n =
1,299). We also excluded those who reported extreme
consumption (>2 times the interquartile ranges of Box-
Cox transformed intake) of total energy (n = 3,771) and
dietary fiber (n = 3,324). Exclusion of individuals report-
ing extreme energy intake is widely used in nutritional
epidemiology studies since these participants are more
likely to over- or under-report their intake [12]. After
exclusions (n = 198,957), the analytic cohort included
367,442 individuals. The NIH-AARP Diet and Health
study was approved by the Special Studies Institutional
Review Board of the US National Cancer Institute. All
participants provided written informed consent.Assessment of dietary exposures
At baseline, dietary intake was assessed with a self-
administered 124-item food frequency questionnaire
(FFQ), which was an early version of the Diet History
Questionnaire developed at the National Cancer Insti-
tute [13,14]. Participants were asked to report their
usual frequency of intake and portion size over the past
12 months using 10 predefined frequency categories
ranging from never to 6+ times per day for beverages
and from never to 2+ times per day for solid foods with
three portion size categories. The food items, portionsizes, and nutrient database were constructed using the
US Department of Agriculture’s 1994–1996 Continuing
Survey of Food Intakes by Individuals. The FFQ used in
the study was calibrated using two non-consecutive
24-hour dietary recalls in 1953 NIH-AARP study par-
ticipants. The nutrient database for dietary fiber was
based on AOAC methods.
The whole grains were defined as the whole grain part
of each product. The US Department of Agriculutre’s
Pyramid Servings Database enabled us to accurately esti-
mate whole-grain intake from all foods in the FFQ. The
sources of whole-grain intake in the FFQ used in our
study were ready-to-eat cereals, high-fiber cereals, other
fiber cereals, whole-grain breads or dinner rolls, cooked
cereal, popcorn, pancakes, waffles, French toast or
crepes, rice or other cooked grains, bagels, English muf-
fins, tortillas, pasta, crackers, chips, cookies or brownies,
sweet pastries, and pies. In this Continuing Survey of Food
Intakes by Individuals dataset., whole grain foods were
defined as those containing at least 25% whole grains and/
or bran. Main fibers are from fruit, grains, vegetables, and
beans in the present study. Cereal fiber was defined as
fiber from all cereals (e.g., ready-to-eat cereals, high-fiber
cereals, cooked cereal, and other fiber cereals) and grain-
based products.
In specifying numbers of deaths by intake quintile,
the number of deaths is determined by the energy-
adjusted intake quintile for the entire population; when
deaths are specific to a sex, we used the quintiles within
the sex. We also collected demographic, anthropomet-
ric, and lifestyle information, including history of smok-
ing (the number of cigarettes smoked per day), time of
smoking cessation (<1 years, 1 to 5 years, 5 to 10 years,
or ≥10 years before baseline), physical activity (never,
rare, 1 to 2, 3 to 4, ≥5 hours/week), alcohol intake (g/day)
family history of cancers, menopausal hormone therapy
use in women, and some medical conditions at baseline.
Ascertaining mortality
The AARP dataset denotes date of death and cause of
death. There are 22 broad categories for cause of death.
The modeling analysis for specific cause of death is per-
formed with the study end date of 2008. For total mor-
tality, models for study end dates in 2008 and 2009 were
designed. Subjects with date of death after the study’s
end date are treated as alive at the end of the study, with
no death or cause of death in the model. When the
study end date was 2008, and there was a date of death
but no cause of death for 2008 or earlier, the subject was
not included in the modeling for cause of death, but
only total mortality. Thus, when specifying numbers of
deaths it depends on both the study end date and whe-
ther the cause of death field is missing. Vital status was
determined through a periodic linkage of the cohort to
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and follow-up searches of the National Death Index Plus
for participants who matched the Social Security Ad-
ministration Death Master File, cancer registry linkage,
questionnaire responses, and responses to other mailings.
The International Classification of Diseases, Ninth Revi-
sion [15] and the International Statistical Classification of
Diseases, 10th Revision [16] were used to define death as
follows: cancer (ICD-9, 140–239; ICD-10, C00–C97 and
D00–D48), CVD (ICD-9, 390–398, 401–404, 410–429,
and 440–448; ICD-10, I00–I13, I20–I51, and I70–I78),
diabetes (ICD-9, 250; ICD-10, E10–E14), respiratory dis-
ease (ICD-9, 480–487 and 490–496; ICD-10, J10–J18 and
J40–J47), infections (ICD-9, 001–139; ICD-10, A00–B99),
and all other/unknown causes.
Statistical analysis
We used the Cox proportional hazards model to esti-
mate hazard ratios (HRs) and two-sided 95% confidence
intervals (CIs) using the SAS PROC PHREG procedure
(Version 9.1; SAS Institute Inc., Cary, NC, USA). Person-
years of follow-up were calculated from the date of the
baseline questionnaire until the date of death or the end
of follow-up (December 31, 2009), whichever occurred
first. Intake of whole grains and cereal fiber were ad-
justed for total energy intake using the residual method
[17], and were categorized into quintiles.
We presented the results from four analysis models.
Model 1, adjusted for age and gender; Model 2, adjusted
for age, gender, the number of cigarettes smoked per day,
and time of smoking cessation (<1 years, 1 to 5 years, 5 to
10 years, or ≥10 years before baseline); Model 3, adjusted
for age, gender, the number of cigarettes smoked per day,
time of smoking cessation (<1 years, 1 to 5 years, 5 to
10 years, or ≥10 years before baseline), race or ethnicity
group, alcohol intake, education level, marital status (yes,
no), health status (poor, fair, good, very good), obesity
(underweight, overweight, obesity), physical activity, con-
sumption of red meat (processed and fresh meat), total
fruit and total vegetables, total energy intake, and hor-
mone usage; and Model 4, based on Model 3 further ad-
justed for cereal fiber (whole grains analysis).
For missing data in each covariate, we created indi-
cator variables. Overall, missing data was less than 5%.
The model results summary includes the results of stat-
istical tests for trend in the response for the risk variable.
Quintiles Trend P denotes the P value when the median
value within the risk variable quintile is included in the
hazard model as linear.
Results
Table 1 shows baseline characteristics of study parti-
cipants (n = 367,442), according to intake of whole
grains and cereal fiber. During an average of 14 years offollow-up (total person-years, 5,148,760), we documented
46,067 deaths, among them 11,283 from CVD, 19,043
from cancer, 371 from diabetes, 3,796 from respiratory
disease, 922 from infection, and 5,223 from other causes.
At baseline, intakes of whole grains and cereal fiber were
inversely correlated with prevalence of overweight, obesity,
and current smoking, as well as intake of red meat. The
levels of moderate and vigorous physical activity were
higher among participants with higher intakes of whole
grains or cereal fiber than those with lower intakes.
Whole grains and cereal fiber intake with total mortality
In age- and gender-adjusted analysis (Model 1), we found
that intake of whole grains were inversely associated with
all-cause mortality (Table 2). As compared with the lowest
quintile, the HRs across increasing quintiles of whole
grain intake were 0.78 (95% CI, 0.76–0.80), 0.70 (95% CI,
0.68–0.72), 0.63 (95% CI, 0.61–0.65), and 0.61 (95% CI,
0.59–0.62) (P trend <0.0001). Further adjustment for smo-
king status and time since smoking cessation (Model 2)
did not appreciably change the associations. When the
models further included race/ethnicity, education, marital
status, self-rated health status, obesity (underweight, over-
weight, and obesity), physical activity, use of menopau-
sal hormone therapy, and intake of alcohol, red meat,
fruits, vegetables, and total energy (Model 3), the high-
est quintile of whole grain intake was associated with
17% (95% CI, 14–19%) lower risk of all-cause mortality
(P trend <0.0001). The associations between whole grain
intake and all-cause mortality was attenuated, the highest
quintile of whole grain intake was associated with 6%
(95% CI, 3–10%) lower risk, but remained significant
when cereal fiber was additionally adjusted (Model 4;
P trend = 0.002). These results suggested that the pro-
tective effects of whole grain may be due, at least in the
main part, to its cereal fiber component.
Similarly, we found that cereal fiber intake was sig-
nificantly associated with all-cause mortality in age-
and gender-adjusted and multivariate-adjusted models
(Models 1, 2 and 3; all P trend <0.0001; Table 3). In
model 3, the highest quintile of cereal intake was asso-
ciated with 19% (16–21%) lower risk of all-cause mor-
tality (P trend <0.0001).
Whole grains and cereal fiber intake with cause-specific
mortality
We next tested the associations for cause-specific mor-
talities. In age- and gender-adjusted and multivariate ad-
justed models (Models 1, 2 and 3), intakes of whole
grains or cereal fiber were inversely associated with risk
of death from CVD, cancer, diabetes, respiratory disease,
infections, and other/unknown causes (all P trend <0.023).
In Model 3, as compared with the lowest quintiles, people
in the highest quintile of whole grain intake had 11%
Table 1 Baseline characteristics of the study participants according to intake of whole grains and cereal fiber
Total
participants
Whole grains Cereal fiber
Q1 Q3 Q5 Q1 Q3 Q5
n 367,442 73,488 73,489 73,489 73,488 73,489 73,489
Age, mean years 61.7 61.1 61.7 62.1 61.0 61.7 62.2
Female, % 43.9 30.7 51.9 40.4 35.0 49.9 40.2
Whites, % 92.9 92.6 92.9 93.2 91.2 93.0 94.4
College graduate, % 41.0 35.2 41.4 44.9 36.2 40.4 46.4
Married, % 68.1 72.7 65.2 68.9 69.8 66.1 69.9
Moderate physical activity (3–4 times/week), % 27.3 23.0 27.8 30.6 23.6 27.2 30.9
Vigorous physical activity (≥5 times/week), % 19.2 17.5 18.0 23.6 18.1 17.6 24.1
Overweight, % 42.4 44.5 42.0 41.0 43.9 42.2 41.1
Obesity, % 19.6 22.7 19.7 16.6 23.6 20.0 15.0
Very good or excellent self-report health, % 61.4 56.5 62.2 64.3 58.8 61.4 65.0
Previous or current use of postmenopausal hormone therapy, % 55.0 47.9 55.6 58.1 45.5 54.4 59.2
Former smoker, % 48.7 48.5 48.2 49.5 47.6 48.4 50.2
Current smoker, % 12.8 21.4 11.3 8.0 21.4 11.5 7.0
Median total energy intake (kcal/d) 1,805 2,394 1,527 1,855 2,330 1,563 1,832
Median alcohol intake (g/d) 14.7 32.5 10.0 8.8 27.5 11.6 9.9
Median servings of food
Red meat (oz/d) 2.0 3.1 1.6 1.7 3.1 1.71 1.6
Fruits (cup eq/d) 2.0 2.1 1.8 2.2 2.3 1.8 2.2
Vegetables (cup eq/d) 1.9 2.2 1.7 2.0 2.3 1.7 2.0
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specific mortality, while people in the highest quintile of
cereal fiber intake had 15% (cancer) to 34% (diabetes)
lower risk of cause-specific mortality.
When cereal fiber was further adjusted, the associations
of whole grains with death from CVD, respiratory disease,
infections, and other causes became non-significant; how-
ever, the associations with death from cancer and diabetes
remained significant (P trend <0.029).
Discussion
In this large prospective cohort study of the US popula-
tion, we found that high consumption of whole grains or
cereal fiber was significantly associated with reduced risk
of all-cause mortality and death from CVD, cancer, dia-
betes, respiratory disease, infections, and other causes.
As compared with individuals with the lowest intake of
whole grains, those in the highest intake group had a
17% lower risk of all-cause mortality and 11 to 48% lower
risk of disease-specific mortality. As compared with indi-
viduals with the lowest intake of cereal fiber, those in the
highest intake group had a 19% lower risk of all-cause
mortality and 15 to 34% lower risk of disease-specific mor-
tality. Furthermore, our results suggested that the protect-
ive effects of whole grains may due, at least in the main
part, to its cereal fiber component.To the best of our knowledge, the present study is,
thus far, the largest in size regarding deaths in a prospec-
tive setting. Our findings are concordant with previously
observed protective effects of whole grain intake on CVD,
diabetes, and certain cancers [18,19]. Based on a meta-
analysis of six cohort studies including 286,125 partici-
pants and 10,944 cases, a two servings per day increment
in whole grain consumption was associated with a 21%
(95% CI, 13–28%) decrease in risk of type 2 diabetes after
adjustment for potential confounders and BMI [5]. These
findings were confirmed by Ye et al.’s meta-analysis [20],
in which it was also reported that compared with never/
rare consumers of whole grains, individuals consuming 48
to 80 g of whole grains per day (3 to 5 serving/day) had
a 21% lower risk of CVD (relative risk = 0.79; 95% CI,
0.74–0.85). Inverse associations were also reported be-
tween intake of whole grains and incident hypertension
[21]. In a meta-analysis of 25 prospective studies, the
summary relative risk of developing colorectal cancer
for 10 g daily of cereal fiber was 0.90 (95% CI, 0.83–0.97),
pooled results from six studies showed the relative risk for
an increment of three servings daily of whole grains was
0.83 (95% CI, 0.78–0.89) [7]. High whole grain intakes
have been related to reduced risk of other cancers, such as
digestive cancer, in prospective studies, although the pro-
tective effects were not consistently observed [22,23].
Table 2 Association of whole grain intake with total and cause-specific mortality
All
participants
Whole grains (oz eq/d) P trend
Q1 (n = 41,248) Q2 (n = 41,248) Q3 (n = 41,249) Q4 (n = 41,248) Q5 (n = 41,249)
0.13 0.30 0.47 0.69 1.20
Causes of death
All cause
No. of deaths 46,067 11,845 9,450 8,694 8,054 8,024
Model 1 1.00 0.78 (0.76–0.80) 0.70 (0.68–0.72) 0.63(0.61–0.65) 0.61 (0.59–0.62) <0.0001
Model 2 1.00 0.88 (0.86–0.91) 0.83 (0.81–0.85) 0.78 (0.75–0.80) 0.77 (0.75–0.79) <0.0001
Model 3 1.00 0.93 (0.90–0.95) 0.89 (0.87–0.92) 0.85 (0.82–0.87) 0.83 (0.81–0.86) <0.0001
Model 4 1.00 0.96 (0.93–0.99) 0.95 (0.92–0.98) 0.92 (0.89–0.96) 0.94 (0.90–0.97) 0.002
Cardiovascular disease
No. of deaths 11,283 2,921 2,330 2,121 1,914 1,997 <0.0001
Model 1 1.00 0.78 (0.74–0.83) 0.69 (0.65–0.73) 0.60 (0.57–0.64) 0.60 (0.57–0.64) <0.0001
Model 2 1.00 0.88 (0.83–0.93) 0.81 (0.77–0.86) 0.73 (0.69–0.77) 0.75 (0.71–0.80) <0.0001
Model 3 1.00 0.93 (0.88–0.98) 0.88 (0.83–0.93) 0.81 (0.77–0.86) 0.83 (0.78–0.88) <0.0001
Model 4 1.00 0.96 (0.91–1.02) 0.95 (0.89–1.01) 0.90 (0.84–0.97) 0.95 (0.88–1.03) 0.188
Cancer
No. of deaths 19,043 4,836 3,912 3,616 3,388 3,291
Model 1 1.00 0.79 (0.76–0.83) 0.71 (0.68–0.75) 0.65 (0.62–0.68) 0.61 (0.59–0.64) <0.0001
Model 2 1.00 0.91 (0.87–0.95) 0.86 (0.83–0.90) 0.82 (0.79–0.86) 0.80 (0.76–0.84) <0.0001
Model 3 1.00 0.94 (0.90–0.98) 0.91 (0.87–0.95) 0.88 (0.84–0.92) 0.85 (0.81–0.89) <0.0001
Model 4 1.00 0.96 (0.92–1.00) 0.95 (0.90–0.99) 0.93 (0.88–0.98) 0.93 (0.88–0.99) 0.025
Diabetes
No. of deaths 371 113 72 73 66 47
Model 1 1.00 0.62 (0.46–0.84) 0.62 (0.46–0.83) 0.54 (0.40–0.73) 0.37 (0.27–0.52) <0.0001
Model 2 1.00 0.67 (0.49–0.90) 0.67 (0.50–0.91) 0.60 (0.44–0.82) 0.42 (0.30–0.60) <0.0001
Model 3 1.00 0.71 (0.53–0.96) 0.76 (0.56–1.03) 0.72 (0.53–0.99) 0.52 (0.37–0.75) 0.0009
Model 4 1.00 0.74 (0.54–1.00) 0.81 (0.59–1.13) 0.78 (0.55–1.13) 0.57 (0.37–0.89) 0.029
Respiratory disease
No. of deaths 3,796 1,123 802 673 606 592
Model 1 1.00 0.69 (0.63–0.75) 0.56 (0.50–0.61) 0.48 (0.43–0.53) 0.45 (0.41–0.50) <0.0001
Model 2 1.00 0.88 (0.80–0.96) 0.79 (0.72–0.87) 0.74 (0.67–0.82) 0.74 (0.67–0.82) <0.0001
Model 3 1.00 0.99 (0.90–1.09) 0.94 (0.85–1.03) 0.91 (0.82–1.01) 0.89 (0.80–0.98) 0.0099
Model 4 1.00 1.02 (0.93–1.12) 1.00 (0.90–1.11) 1.01 (0.90–1.14) 1.03 (0.91–1.18) 0.67
Infections
No. of deaths 922 251 184 163 161 163
Model 1 1.00 0.71 (0.59–0.86) 0.61 (0.50–0.75) 0.58 (0.48–0.71) 0.57 (0.47–0.70) <0.0001
Model 2 1.00 0.78 (0.64–0.94) 0.69 (0.57–0.84) 0.68 (0.55–0.83) 0.68 (0.55–0.83) 0.0002
Model 3 1.00 0.84 (0.70–1.02) 0.78 (0.64–0.96) 0.79 (0.65–0.97) 0.77 (0.62–0.95) 0.02
Model 4 1.00 0.87 (0.71–1.06) 0.83 (0.67–1.04) 0.87 (0.69–1.10) 0.89 (0.68–1.16) 0.54
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Table 2 Association of whole grain intake with total and cause-specific mortality (Continued)
Other/unknown causes
No. of deaths 5,223 1,206 1,058 1,038 940 981
Model 1 1.00 0.86 (0.79–0.93) 0.82 (0.76–0.90) 0.71 (0.66–0.78) 0.72 (0.66–0.78) <0.0001
Model 2 1.00 0.91 (0.84–0.99) 0.90 (0.83–0.98) 0.80 (0.73–0.87) 0.81 (0.74–0.88) <0.0001
Model 3 1.00 0.97 (0.88–1.06) 0.97 (0.89–1.06) 0.87 (0.79–0.96) 0.86 (0.78–0.94) 0.0001
Model 4 1.00 0.99 (0.91–1.09) 1.03 (0.93–1.13) 0.96 (0.86–1.06) 0.98 (0.87–1.09) 0.54
Data are hazard ratios (HR) and 95% confidence interval (CI). The numbers of deaths are for participants who died during follow-up. The co-variables are
baseline assessments.
Model 1, Adjusted for age and gender; Model 2, Adjusted for age, gender, the number of cigarettes smoked per day, and time of smoking cessation (<1 years,
1 to 5 years, 5 to 10 years, or ≥10 years before baseline); Model 3, Adjusted for age, gender, the number of cigarettes smoked per day, time of smoking cessation
(<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), race or ethnicity group, alcohol intake, education level, marital status (yes, no), health status
(poor, fair, good, very good), obesity (underweight, overweight, obesity), physical activity, consumption of red meat, total fruit and total vegetables, total energy
intake, and hormone usage. Model 4, Based on Model 3 further adjusted for cereal fiber.
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ship between whole grains and their components with
mortality in humans. Our findings are consistent with
the results reported in the Nurses’ Health Study, in
which whole grain intake, especially bran, was associ-
ated with lower all-cause and CVD mortality in diabetic
women [24]. Similarly, higher fiber intake was associa-
ted with lower total mortality, particularly mortality from
circulatory, digestive, and non-CVD non-cancer inflam-
matory diseases in a large European prospective study
of 452,717 men and women [25]. In a previous analysis
among our study samples, it was found that intake of
fiber from grains but not from other sources was inversely
related to all-cause mortality and death from cancer, CVD,
infections, and respiratory disease [9]. In this updated ana-
lysis, we found cereal fiber intake was inversely associated
with death from diabetes. However, we did not report the
associations of specific types of whole grain foods/pro-
ducts with mortality and cause-specific mortality, since it
is hard to further differentiate such food groups; this pre-
sents a limitation of this observational study.
In addition, we found that the associations of whole
grains with death from CVD, respiratory disease, and in-
fections became non-significant after adjustment for
cereal fiber intake. The associations with total mortality
and death from cancer and diabetes were also largely at-
tenuated, although they remained significant after adjust-
ment for cereal fiber intake. These observations suggest
that the protective effects of whole grains on mortality are
at least partly mediated by its cereal fiber component.
Such a postulation is supported by previous evidence that
shows cereal fiber intake is related to an improvement of
insulin sensitivity and lipid profile, an increase in protect-
ive molecules such as adiponectin, and a reduction in in-
flammation markers [26-28].
The protective effect of whole grains and fiber con-
sumption on risk of mortality is biologically plausible.
Dietary fiber intake is associated with lower levels of
inflammation markers, such as C-reactive protein, andtumor necrosis factor α receptor 2, which play key roles
in chronic inflammatory conditions [29,30]. Whole grain
foods are rich in fiber. Therefore, the anti-inflammatory
effects of dietary fiber may help explain, at least in part,
the inverse associations of whole grains and fiber con-
sumption with chronic disease death. Moreover, whole
grains and cereal fiber have a high content of antioxidants,
vitamins, trace minerals, phenolic acids, lignans, and
phytoestrogens, which have been associated with a re-
duced risk of colorectal cancer [31] and lower risk of
death from non-cardiovascular, non-cancer inflamma-
tory diseases and respiratory system diseases [32]. In
addition, dietary fibers have specific and unique impacts
on intestinal microbiota composition and metabolism
[33,34]. Additionally, recent studies have related gut mi-
crobiota with various chronic diseases such as obesity,
CVD, diabetes, and cancer [34,35]. Further functional
investigations are warranted to verify these potential
mechanisms.
Strengths and limitations of the study
In our study cohort, both whole grains and cereal fiber
were correlated with high levels of physical activity and
better health status, as well as with low BMI, low levels
of smoking, and low intakes of alcohol and red meat.
However, our results were less likely due to the potential
confounding of these factors because careful adjustment
for these factors in our analyses did not significantly
change the results. Nevertheless, we acknowledge that
the positive associations may still be related to residual
confounding of non-measured covariates. Reverse caus-
ality might also affect the associations, since people with
chronic disease might modify their eating habits by con-
suming healthy foods including those rich in whole
grains and cereal fiber. In our analyses, however, we have
excluded patients with cancer, heart disease, and dia-
betes at baseline and only analyzed the associations with
incident cases. Whole grains and cereal fiber intakes
were evaluated by self-report at a single time point. It is
Table 3 Association of cereal fiber intake with total and cause-specific mortality
All
participants
Cereal fiber (g/d) P trend
Q1 (n = 73,488) Q2 (n = 73,488) Q3 (n = 73,489) Q4 (n = 73,488) Q5 (n = 73,489)
2.02 4.15 5.27 6.65 10.22
Causes of death
All cause
No. of deaths 46,067 11,700 9,652 8,664 8,133 7,918
Model 1 1.00 0.80 (0.78–0.83) 0.70 (0.68–0.72) 0.64 (0.62–0.66) 0.59 (0.58–0.61) <0.0001
Model 2 1.00 0.89 (0.87–0.92) 0.83 (0.81–0.85) 0.78 (0.76–0.81) 0.76 (0.73–0.78) <0.0001
Model 3 1.00 0.93 (0.90–0.95) 0.87 (0.85–0.90) 0.84 (0.81–0.86) 0.81 (0.79–0.84) <0.0001
Cardiovascular disease 11,283
No. of deaths 2,901 2,368 2,094 1,986 1,934
Model 1 1.00 0.80 (0.76–0.85) 0.69 (0.65–0.73) 0.63 (0.59–0.66) 0.57 (0.54–0.61) <0.0001
Model 2 1.00 0.88 (0.83–0.93) 0.80 (0.76–0.85) 0.76 (0.71–0.80) 0.72 (0.68–0.76) <0.0001
Model 3 1.00 0.93 (0.87–0.98) 0.86 (0.81–0.91) 0.83 (0.78–0.88) 0.80 (0.75–0.85) <0.0001
Cancer
No. of deaths 19,043 4,772 3,974 3,616 3,391 3,290
Model 1 1.00 0.81 (0.78–0.85) 0.72 (0.69–0.76) 0.66 (0.63–0.69) 0.61 (0.59–0.64) <0.0001
Model 2 1.00 0.91 (0.87–0.95) 0.87 (0.83–0.91) 0.83 (0.79–0.86) 0.80 (0.77–0.84) <0.0001
Model 3 1.00 0.94 (0.90–0.98) 0.90 (0.86–0.95) 0.87 (0.83–0.91) 0.85 (0.81–0.89) <0.0001
Diabetes
No. of deaths 371 92 92 72 57 51
Model 1 1.00 0.92 (0.69–1.22) 0.70 (0.52–0.95) 0.54 (0.39–0.74) 0.45 (0.32–0.64) <0.0001
Model 2 1.00 0.97 (0.73–1.29) 0.77 (0.56–1.04) 0.60 (0.43–0.83) 0.52 (0.37–0.73) <0.0001
Model 3 1.00 1.00 (0.74–1.35) 0.83 (0.60–1.15) 0.70 (0.50–0.99) 0.66 (0.46–0.94) 0.005
Respiratory disease
No. of deaths 3,796 1,082 866 652 649 547
Model 1 1.00 0.75 (0.68–0.82) 0.54 (0.49–0.59) 0.52 (0.47–0.57) 0.42 (0.38–0.46) <0.0001
Model 2 1.00 0.91(0.83–1.00) 0.76 (0.69–0.84) 0.80 (0.72–0.88) 0.70 (0.63–0.78) <0.0001
Model 3 1.00 0.98 (0.89–1.08) 0.82 (0.74–0.91) 0.89 (0.80–0.99) 0.79 (0.71–0.88) <0.0001
Infections
No. of deaths 922 230 210 165 157 160
Model 1 1.00 0.87 (0.72–1.05) 0.66 (0.54–0.81) 0.61 (0.50–0.75) 0.60 (0.49–0.74) <0.0001
Model 2 1.00 0.94 (0.78–1.13) 0.75 (0.61–0.91) 0.71 (0.58–0.87) 0.71 (0.58–0.88) 0.0002
Model 3 1.00 1.04 (0.85–1.27) 0.84 (0.68–1.05) 0.82 (0.66–1.02) 0.83 (0.67–1.03) 0.023
Other/unknown causes
No. of deaths 5,223 1,215 1,050 1,044 963 951
Model 1 1.00 0.84 (0.77–0.91) 0.81 (0.74–0.88) 0.72 (0.66–0.78) 0.67 (0.62–0.73) <0.0001
Model 2 1.00 0.88 (0.81–0.96) 0.88 (0.81–0.95) 0.79 (0.73–0.87) 0.76 (0.70–0.83) <0.0001
Model 3 1.00 0.90 (0.83–0.99) 0.91 (0.83–0.99) 0.83 (0.76–0.91) 0.79 (0.72–0.87) <0.0001
Data are hazard ratios (HR) and 95% confidence interval (CI). The numbers of deaths are for participants who died during follow-up. The co-variables are
baseline assessments.
Model 1, Adjusted for age and gender; Model 2, Adjusted for age, gender, the number of cigarettes smoked per day, and time of smoking cessation (<1 years,
1 to 5 years, 5 to 10 years, or ≥10 years before baseline); Model 3, Adjusted for age, gender, the number of cigarettes smoked per day, time of smoking cessation
(<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), race or ethnicity group, alcohol intake, education level, marital status (yes, no), health status
(poor, fair, good, very good), obesity (underweight, overweight, obesity), physical activity, consumption of red meat, total fruit and total vegetables, total energy
intake, and hormone usage.
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(14 years on average) follow-up period, and such temporal
patterns were not reflected in our analysis. Moreover,
the observational nature of our study limits causality
inference between intakes of whole grains or cereal fiber
and mortality.
Conclusions
Data from our study indicate that intake of whole grains
and cereal fiber may reduce the risk of all-cause mor-
tality and death from chronic diseases such as cancer,
CVD, diabetes, respiratory disease, infections, and other
causes. Disappearance or attenuation of whole grain as-
sociations with total mortality and death from chronic
diseases after adjustment for cereal fiber intake suggests
that cereal fiber partly accounts for the protective effects
of whole grains on mortality.
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